Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule
Clinical trial NCT02161276 · COMPLETED
Trial details
- NCT number
- NCT02161276
- Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-08-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.